Amedeo's Top 20

Amedeo Smart

Independent Medical Education

24 December 2012

Multidisciplinary Journal Club

  1. Agnelli G , Buller HR, Cohen A, Curto M, et al.
    Apixaban for Extended Treatment of Venous Thromboembolism.
    N Engl J Med 2012.

  1. Marcellin P , Gane E, Buti M, Afdhal N, et al.
    Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.
    Lancet 2012.

  2. Davies C , Pan H, Godwin J, Gray R, et al.
    Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
    Lancet 2012.

  3. Bayer O , Reinhart K, Kohl M, Kabisch B, et al.
    Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: A prospective sequential analysis*
    Crit Care Med 2012;40:2543-2551.

  4. McKnight SL .
    Pure genes, pure genius.
    Cell 2012;150:1100-2.

  1. Ryan CJ , Smith MR, de Bono JS, Molina A, et al.
    Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy.
    N Engl J Med 2012.

  2. Press OW , Unger JM, Rimsza LM, Friedberg JW, et al.
    Phase III Randomized Intergroup Trial of CHOP Plus Rituximab Compared With CHOP Chemotherapy Plus 131Iodine-Tositumomab for Previously Untreated Follicular Non-Hodgkin Lymphoma: SWOG S0016.
    J Clin Oncol 2012.

  3. Leblond V , Johnson S, Chevret S, Copplestone A, et al.
    Results of a Randomized Trial of Chlorambucil Versus Fludarabine for Patients With Untreated Waldenstrom Macroglobulinemia, Marginal Zone Lymphoma, or Lymphoplasmacytic Lymphoma.
    J Clin Oncol 2012.

  4. Adetifa IM , Ota MO, Jeffries D, Lugos M, et al.
    Interferon Gamma ELISPOT as a Biomarker of Treatment Efficacy in Latent Tuberculosis Infection: A Clinical Trial.
    Am J Respir Crit Care Med 2012.

  5. Di Lisio L , Martinez N, Montes-Moreno S, Piris-Villaespesa M, et al.
    The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas.
    Blood 2012;120:1782-90.

  1. Iii FA , Kozhaya L, Rawlings SA, Reyes-Robles T, et al.
    CCR5 is a receptor for Staphylococcus aureus leukotoxin ED.
    Nature 2012.

  2. Nadelman RB , Hanincova K, Mukherjee P, Liveris D, et al.
    Differentiation of reinfection from relapse in recurrent Lyme disease.
    N Engl J Med 2012;367:1883-90.

  3. Burmester GR , Weinblatt ME, McInnes IB, Porter D, et al.
    Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis.
    Ann Rheum Dis 2012.

  4. Buck D , Albrecht E, Aslam M, Goris A, et al.
    Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis.
    Ann Neurol 2012.

  5. Kamlin CO , O'Connell LA, Morley CJ, Dawson JA, et al.
    A Randomized Trial of Stylets for Intubating Newborn Infants.
    Pediatrics 2012.

  1. Scholz CW , Pinto A, Linkesch W, Linden O, et al.
    90Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical Trial.
    J Clin Oncol 2012.

  2. Neurath MF , Travis SP.
    Mucosal healing in inflammatory bowel diseases: a systematic review.
    Gut 2012;61:1619-35.

  3. Binkley N , Bolognese M, Sidorowicz-Bialynicka A, Vally T, et al.
    A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.
    J Bone Miner Res 2012;27:1821-9.

  4. Singh G , Hsia-Lin A, Skiest D, Germain M, et al.
    Successful Kidney Transplantation From a Hepatitis B Surface Antigen-Positive Donor to an Antigen-Negative Recipient Using a Novel Vaccination Regimen.
    Am J Kidney Dis 2012.

  5. Nolan R , Gelfand JM, Green AJ.
    Fingolimod treatment in multiple sclerosis leads to increased macular volume.
    Neurology 2012.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016